EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES: AN OPEN-LABEL, PHASE-III, EXTENSION STUDY

被引：4
|
作者：
Brogan, P. A. [1 ,2 ]
Hofer, M. [3 ]
Kuemmerle-Deschner, J. B. [4 ]
Lauwerys, B. [5 ,6 ]
Speziale, A. [7 ]
Leon, K. [8 ]
Wei, X. [9 ]
Laxer, R. [10 ]
机构：
[1] UCL Inst Child Hlth, Dept Infect Inflammat & Rheumatol, London, England
[2] Great Ormond St Hosp NHS Fdn Trust, London, England
[3] Hosp Univ Vaudois, Unite Romande Rhumatol Pediat, Lausanne, Switzerland
[4] Univ Hosp Tuebingen, Tubingen, Germany
[5] Clin Univ St Luc, Brussels, Belgium
[6] Catholic Univ Louvain, Brussels, Belgium
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharmaceut, Beijing, Peoples R China
[10] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4865
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0503
引用
收藏
页码：620 / 621
页数：2
相关论文
共 50 条
  • [21] CANAKINUMAB PHARMACOKINETICS IN PATIENTS YOUNGER THAN 2 YEARS OLD WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES
    Kalabus, J.
    Uziel, Y.
    Brogan, P.
    Hofer, M.
    Kuemmerle-Deschner, J.
    Lauwerys, B.
    Speziale, A.
    Laxer, R.
    Lachmann, H.
    Sun, H.
    Abrams, K.
    Leon, K.
    Junge, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 849 - 849
  • [22] A 16-week open-label study on the efficacy and safety of canakinumab treatment in urticarial vasculitis
    Krause, K.
    Mahamed, A.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E12 - E12
  • [23] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
  • [24] Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
    Hoffman, Hal M.
    Throne, Martin L.
    Amar, Niran J.
    Cartwright, Robert C.
    Kivitz, Alan J.
    Soo, Yuhwen
    Weinstein, Steven P.
    CLINICAL THERAPEUTICS, 2012, 34 (10) : 2091 - 2103
  • [25] Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
    Zhu, Xiaona
    Fan, Jiaqi
    Huang, Yanyan
    Xu, Yongbin
    Yang, Zhi
    Weng, Ruohang
    Luo, Ying
    Yang, Jun
    He, Tingyan
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [26] EFFECTIVENESS OF CHILDHOOD VACCINATIONS IN CAPS PATIENTS TREATED WITH CANAKINUMAB: RESULTS FROM AN OPEN-LABEL PHASE 3 EXTENSION STUDY
    Brogan, P.
    Hofer, M.
    Kuemmerle-Deschner, J.
    Lauwerys, B.
    Speziale, A.
    Wei, X.
    Laxer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 393 - 393
  • [27] Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
    van Vollenhoven, Ronald F.
    Hahn, Bevra H.
    Tsokos, George C.
    Lipsky, Peter
    Gordon, Robert M.
    Fei, Kaiyin
    Lo, Kim Hung
    Chevrier, Marc
    Rose, Shawn
    Berry, Pamela
    Yao, Zhenling
    Karyekar, Chetan S.
    Zuraw, Qing
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (04) : 380 - 387
  • [28] Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
    Gattorno, Marco
    Obici, Laura
    Cattalini, Marco
    Tormey, Vincent
    Abrams, Ken
    Davis, Nicole
    Speziale, Antonio
    Bhansali, Suraj G.
    Martini, Alberto
    Lachmann, Helen J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) : 173 - 178
  • [29] Update of An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)
    Fenaux, Pierre
    Kantarjian, Hagop M.
    Muus, Petra
    Lyons, Roger M.
    Larson, Richard A.
    Sekeres, Mikkael A.
    Becker, Pamela S.
    Jia, Catherine
    Yang, Allen S.
    BLOOD, 2011, 118 (21) : 1193 - 1194
  • [30] Efficacy and Safety of Canakinumab in Patients with Cryopyrin Associated Periodic Syndrome: Results From Meta-Analysis of 5 Studies
    Lachmann, Helen J.
    Kuemmerle-Deschner, Jasmin B.
    Heike, Toshio
    Hara, Toshiro
    Yokota, Shumpei
    Mckernan, Phil
    Widmer, Albert
    Davis, Nicole
    Hachulla, Eric
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S321 - S322
12345